Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis
L Amitrano, MA Guardascione, V Brancaccio… - Journal of …, 2004 - Elsevier
BACKGROUND/AIMS: Portal vein thrombosis in patients with liver cirrhosis is usually
associated to hepatocellular carcinoma. Clinical presentation of non-neoplastic portal vein …
associated to hepatocellular carcinoma. Clinical presentation of non-neoplastic portal vein …
Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis
L Amitrano, MA Guardascione… - Journal of clinical …, 2010 - journals.lww.com
Safety and Efficacy of Anticoagulation Therapy With Low Mole... : Journal of Clinical
Gastroenterology Safety and Efficacy of Anticoagulation Therapy With Low Molecular Weight …
Gastroenterology Safety and Efficacy of Anticoagulation Therapy With Low Molecular Weight …
Prognostic factors in noncirrhotic patients with splanchnic vein thromboses
L Amitrano, MA Guardascione… - Official journal of the …, 2007 - journals.lww.com
RESULTS SVT was an incidental finding in 34 (28.1%) patients; 34 (28.1%) presented with
abdominal infarction; 39 (32.2%) had bowel ischemia or acute portal vein thrombosis; 14 …
abdominal infarction; 39 (32.2%) had bowel ischemia or acute portal vein thrombosis; 14 …
Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis
L Amitrano, V Brancaccio, MA Guardascione… - Hepatology, 2000 - journals.lww.com
The prevalence and pathogenesis of portal vein thrombosis (PVT) in patients with cirrhosis
without hepatocellular carcinoma are not clearly defined. The role of thrombophilic genetic …
without hepatocellular carcinoma are not clearly defined. The role of thrombophilic genetic …
Effects of early placement of transjugular portosystemic shunts in patients with high-risk acute variceal bleeding: a meta-analysis of individual patient data
O Nicoară-Farcău, G Han, M Rudler, D Angrisani… - Gastroenterology, 2021 - Elsevier
Background & Aims Compared with drugs plus endoscopy, placement of transjugular
portosystemic shunt within 72 hours of admission to the hospital (early or preventive …
portosystemic shunt within 72 hours of admission to the hospital (early or preventive …
[HTML][HTML] Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS
Background & Aims The relationship between acute-on-chronic liver failure (ACLF) and
acute variceal bleeding (AVB) is poorly understood. Specifically, the prevalence and …
acute variceal bleeding (AVB) is poorly understood. Specifically, the prevalence and …
The effectiveness of current acute variceal bleed treatments in unselected cirrhotic patients: refining short-term prognosis and risk factors
L Amitrano, MA Guardascione, F Manguso… - Official journal of the …, 2012 - journals.lww.com
OBJECTIVES: The mortality from esophageal variceal hemorrhage in liver cirrhosis patients
remains approximately 15–20%. Predictors of short-term outcomes, such as the hepatic …
remains approximately 15–20%. Predictors of short-term outcomes, such as the hepatic …
[PDF][PDF] Preemptive‐TIPS improves outcome in high‐risk variceal bleeding: an observational study
V Hernández‐Gea, B Procopet, Á Giráldez… - …, 2019 - Wiley Online Library
Patients admitted with acute variceal bleeding (AVB) and Child‐Pugh C score (CP‐C) or
Child‐Pugh B plus active bleeding at endoscopy (CP‐B+ AB) are at high risk for treatment …
Child‐Pugh B plus active bleeding at endoscopy (CP‐B+ AB) are at high risk for treatment …
Coagulation abnormalities in cirrhotic patients with portal vein thrombosis.
L Amitrano, MA Guardascione, PR Ames - Clinical laboratory, 2007 - europepmc.org
The liver has a central role in the clotting process and an altered haemostasis is common in
advanced liver disease. Nevertheless, recent studies have questioned the historical belief …
advanced liver disease. Nevertheless, recent studies have questioned the historical belief …
MELD score and hepatocellular carcinoma identify patients at different risk of short-term mortality among cirrhotics bleeding from esophageal varices
L Amitrano, MA Guardascione, R Bennato… - Journal of …, 2005 - Elsevier
BACKGROUND/AIMS: The role of model for end stage liver disease (MELD) and the
presence of hepatocellular carcinoma (HCC) as risk factors of short-term mortality in patients …
presence of hepatocellular carcinoma (HCC) as risk factors of short-term mortality in patients …